- Phare
- Validé par KD/KO
Anticorps Recombinant de lapin anti-IFITM2
IFITM2 Recombinant Antibody for WB, IF/ICC, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IF/ICC, FC (Intra), ELISA
Conjugaison
Non conjugué
CloneNo.
240318B6
N° de cat : 83455-5-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HeLa, cellules A549, cellules HepG2, cellules MCF-7, cellules SGC-7901 |
| Résultats positifs en IF/ICC | cellules HepG2, |
| Résultats positifs en FC (Intra) | cellules MCF-7, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
83455-5-RR cible IFITM2 dans les applications de WB, IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | IFITM2 Protéine recombinante Ag3451 |
| Nom complet | interferon induced transmembrane protein 2 (1-8D) |
| Masse moléculaire calculée | 132 aa, 15 kDa |
| Poids moléculaire observé | 15 kDa |
| Numéro d’acquisition GenBank | BC009696 |
| Symbole du gène | IFITM2 |
| Identification du gène (NCBI) | 10581 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
IFITM2, also named as 1-8D, belongs to the CD225 family. It is an IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus, by inhibiting the early steps of replication. IFITM2 induces cell cycle arrest and mediates apoptosis by caspase activation and in a p53-independent manner. It is overexpressed in colon carcinoma. IFITM2 is a novel pro-apoptotic gene that will provide new insights into the regulated cellular pathways to death. IFITM proteins are recently identified as viral restriction factors that inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. Also, they serve as important components of the innate immune system to restrict HIV-1 infection.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for IFITM2 antibody 83455-5-RR | Download protocol |
| IF protocol for IFITM2 antibody 83455-5-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |






